IGM Biosciences Inc (IGMS)

IGM Biosciences Inc Aktie (IGMS) Neueste Nachrichten

IGM Biosciences, Inc. (IGMS) Reports Q1 Loss, Misses Revenue Estimates

Zacks Investment Research

IGM Biosciences Announces First Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire Inc.

Soft Instrument Orders Likely to Hurt PacBio's (PACB) Q1 Earnings

Zacks Investment Research

Intra-Cellular Therapies (ITCI) Reports Q1 Loss, Tops Revenue Estimates

Zacks Investment Research

Akoya Biosciences (AKYA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Zacks Investment Research

IGM Biosciences, Inc. (IGMS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Zacks Investment Research

IGM Biosciences (IGMS) Upgraded to Buy: What Does It Mean for the Stock?

Zacks Investment Research

Analyzing How You Should Play Cigna (CI) Ahead of Q1 Earnings

Zacks Investment Research

What 5 Analyst Ratings Have To Say About IGM Biosciences

Benzinga

IGM Biosciences Announces Refocusing of Sanofi Collaboration

GlobeNewswire Inc.

Nurix Therapeutics, Inc. (NRIX) Reports Q1 Loss, Tops Revenue Estimates

Zacks Investment Research

IGM Biosciences to Present at the Stifel 2024 Virtual Targeted Oncology Forum

GlobeNewswire Inc.

Where IGM Biosciences Stands With Analysts

Benzinga

IGM Biosciences, Inc. (IGMS) Reports Q4 Loss, Lags Revenue Estimates

Zacks Investment Research

IGM Biosciences Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

GlobeNewswire Inc.

Wall Street Analysts Think IGM Biosciences, Inc. (IGMS) Could Surge 63.1%: Read This Before Placing a Bet

Zacks Investment Research

Strength Seen in iTeos Therapeutics, Inc. (ITOS): Can Its 7.4% Jump Turn into More Strength?

Zacks Investment Research

Wall Street Analysts Believe IGM Biosciences, Inc. (IGMS) Could Rally 35.08%: Here's is How to Trade

Zacks Investment Research

Why Big Lots Shares Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Benzinga

CymaBay Therapeutics, ContextLogic, Snap And Other Big Stocks Moving Higher On Monday

Benzinga

RBC Capital's Rating Upgrade Propels IGM Biosciences Into Immunology Limelight

Benzinga

Why Take-Two Interactive Software Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Benzinga

SPS Commerce Posts Upbeat Results, Joins Masonite International, Impinj And Other Big Stocks Moving Higher On Friday

Benzinga

Morgan Stanley Reports Q4 Results, Joins Boeing, Alcoa And Other Big Stocks Moving Lower On Tuesday

Benzinga

IGM Bio (IGMS) Stock Rallies 142% in 3 Months: Here's Why

Zacks Investment Research

Acuity Brands Posts Upbeat Earnings, Joins Accolade, Urban Outfitters And Other Big Stocks Moving Higher On Tuesday

Benzinga

IGM Biosciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire Inc.

ZimVie Agrees To Sell Its Spine Business, Joins United States Steel, PGT Innovations And Other Big Stocks Moving Higher On Monday

Benzinga

What To Know About HC Wainwright & Co.'s Downgrade of IGM Biosciences

Benzinga

Analyst Ratings for IGM Biosciences

Benzinga

IGM Biosciences Announces Strategic Pipeline Prioritization and Cash Runway Extension

GlobeNewswire Inc.

Does IGM Biosciences, Inc. (IGMS) Have the Potential to Rally 268.31% as Wall Street Analysts Expect?

Zacks Investment Research

Where IGM Biosciences Stands With Analysts

Benzinga

IGM Biosciences Announces Third Quarter 2023 Financial Results

GlobeNewswire Inc.